Greenline Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $399K | Sell |
3,313
-840
| -20% | -$97K | 0.04% | 132 |
|
|
2025
Q4 | $437K | Buy |
4,153
+1,328
| +47% | +$125K | 0.05% | 127 |
|
|
2025
Q3 | $237K | Sell |
2,825
-868
| -24% | -$71.5K | 0.03% | 137 |
|
|
2025
Q2 | $292K | Sell |
3,693
-10
| -0.3% | -$795 | 0.04% | 131 |
|
|
2025
Q1 | $332K | Buy |
3,703
+124
| +3% | +$11.6K | 0.05% | 121 |
|
|
2024
Q4 | $356K | Hold |
3,579
| – | – | 0.05% | 120 |
|
|
2024
Q3 | $406K | Hold |
3,579
| – | – | 0.06% | 117 |
|
|
2024
Q2 | $458K | Buy |
3,579
+200
| +6% | +$25.8K | 0.07% | 104 |
|
|
2024
Q1 | $446K | Hold |
3,379
| – | – | 0.07% | 98 |
|
|
2023
Q4 | $368K | Hold |
3,379
| – | – | 0.06% | 102 |
|
|
2023
Q3 | $348K | Hold |
3,379
| – | – | 0.07% | 95 |
|
|
2023
Q2 | $390K | Hold |
3,379
| – | – | 0.07% | 95 |
|
|
2023
Q1 | $359K | Hold |
3,379
| – | – | 0.07% | 110 |
|
|
2022
Q4 | $375K | Hold |
3,379
| – | – | 0.07% | 111 |
|
|
2022
Q3 | $291K | Hold |
3,379
| – | – | 0.07% | 107 |
|
|
2022
Q2 | $308K | Hold |
3,379
| – | – | 0.07% | 104 |
|
|
2022
Q1 | $277K | Sell |
3,379
-1,799
| -35% | -$142K | 0.05% | 108 |
|
|
2021
Q4 | $397K | Hold |
5,178
| – | – | 0.07% | 97 |
|
|
2021
Q3 | $389K | Hold |
5,178
| – | – | 0.08% | 86 |
|
|
2021
Q2 | $403K | Sell |
5,178
-249
| -5% | -$18.5K | 0.08% | 89 |
|
|
2021
Q1 | $399K | Sell |
5,427
-22
| -0.4% | -$1.62K | 0.09% | 84 |
|
|
2020
Q4 | $425K | Buy |
5,449
+22
| +0.4% | +$1.68K | 0.1% | 84 |
|
|
2020
Q3 | $430K | Hold |
5,427
| – | – | 0.11% | 73 |
|
|
2020
Q2 | $400K | Sell |
5,427
-22,648
| -81% | -$1.7M | 0.11% | 82 |
|
|
2020
Q1 | $2.06M | Sell |
28,075
-8,466
| -23% | -$665K | 0.67% | 49 |
|
|
2019
Q4 | $3.17M | Sell |
36,541
-21,637
| -37% | -$1.78M | 0.8% | 43 |
|
|
2019
Q3 | $4.67M | Buy |
58,178
+806
| +1% | +$64.6K | 1.34% | 26 |
|
|
2019
Q2 | $4.59M | Sell |
57,372
-6,617
| -10% | -$507K | 1.45% | 28 |
|
|
2019
Q1 | $5.08M | Buy |
63,989
+98
| +0.2% | +$7.33K | 1.66% | 22 |
|
|
2018
Q4 | $4.32M | Hold |
63,891
| – | – | 1.35% | 27 |
|
|
2018
Q3 | $4.32M | Buy |
63,891
+1,555
| +2% | +$99.1K | 1.35% | 27 |
|
|
2018
Q2 | $3.61M | Buy |
62,336
+2,522
| +4% | +$142K | 1.18% | 33 |
|
|
2018
Q1 | $3.11M | Buy |
59,814
+27,451
| +85% | +$1.48M | 1.03% | 34 |
|
|
2017
Q4 | $1.74M | Buy |
+32,363
| New | +$1.79M | 0.58% | 45 |
|
Other funds holding MRK
VCM
VPM
Greenline Partners's MRK Position: Q1 2026 in Review
Greenline Partners reduced its Merck (MRK) stake by 20% in Q1 2026, selling an estimated $97K and leaving 3,313 shares worth $399K. The position accounts for 0.04% of the portfolio, ranked #132.
Greenline Partners first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.08M in Q1 2019. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Greenline Partners held 3,313 shares of Merck worth $399K as of Q1 2026.
- Greenline Partners sold 840 Merck shares in Q1 2026, an estimated $97K.
- Merck made up 0.04% of Greenline Partners's portfolio in Q1 2026, its #132 holding.
- Greenline Partners first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- Greenline Partners's Merck position peaked at $5.08M in Q1 2019.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Greenline Partners's 13F filing for Q1 2026, filed 15 May 2026.